Oral Health Status in a Group of Egyptian Children With Cerebral Palsy: A Cross-sectional Study

Sponsor
Cairo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05650593
Collaborator
(none)
500
1
6.8
73.5

Study Details

Study Description

Brief Summary

The aim of the study is to assess the oral health status in a group of Egyptian children with cerebral palsy.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Cerebral palsy (CP) is a group of neuromuscular disorders affecting the development of movement and posture, causing activity limitations. Disturbances to the development of the infant brain may occur early either in utero, during birth or in the first few months of infancy.It may be due to infection, trauma, hypoxia, or hyperbilirubinemia in addition to genetic and biochemical factors. Subsequently, there will be limitations in muscular activity. CP is the most common motor disability occurring during childhood. The prevalence of CP around the world ranges from 1.5 to >4/1000 live births in the developed countries (Al Hashmi et al. 2017).

    The CP classification includes four types: spastic, dyskinetic, hypotonic, and mixed, the spastic type being the most common and at times most severe one. Manifestations of cerebral palsy can take on a vast spectrum from minimal symptoms such as minor movement limitation to spasms, muscular rigidity, confinement in a wheelchair, poor bowel control and respiratory problems (Răducanu, Anca et al. 2008).

    The patients with cerebral dysfunction may also display mental retardation, epilepsy, sensorial deficiencies (sight and hearing impairment), persistent primitive reflexes, attention-, memory-, learningand emotional problems, language and speaking disturbances (Amit Mani et al. 2015) .

    Patients with CP have numerous oral health problems. Neuromuscular disturbances can affect oral health significantly; they may result in changes of the orofacial region's structure and may affect the development of parafunctional habits, including feeding problems, difficulty maintaining oral hygiene (OH), and barriers to oral care access. Malocclusions and tooth wear are common. Experience of dental trauma is also highly prevalent due to instability as a result of neuromuscular defects or seizures (Du et al. 2010).

    Children with CP display the same oral pathology as healthy persons. However, they present a higher susceptibility to several oro-dental diseases (dental caries, periodontal disease, dental trauma, malocclusion, bruxism, temporomandibular joint disorders, enamel hypoplasia, abnormal oral habits - tongue thrust, mouth breathing, drooling etc.) due to the abnormal neuromuscular coordination of the tongue, lips, and cheeks and to the low level and the reduced quality of the oral care. The treatment of CP is complex and multidisciplinary, consisting in general (kinetotherapy, surgical interventions, myorelaxants medication) and oral treatment (behavior management, prophylactic, curative) (Sedky 2017).

    Parental counselling about diet, oral hygiene procedures and the use of fluorides are preferred to begin as early as possible. Local anaesthesia is not contraindicated; nevertheless sedation is useful to reduce nausea and lingual dystonia, anxiolytic and muscle relaxant drugs such as diazepam are useful as premedication. In some patients, because of uncontrollable movements or poor cooperation, dental treatment has to be carried out under general anaesthesia. Regarding patient access to dental chair, some patients can be treated in their wheelchairs. Preoperative mouthwashes are prevented better administered as a gel or spray) .use of rubber dam and powerful aspiration are needed. The dental chair should be moved slowly to prevent spastic muscle responses (Wasnik et al. 2020).

    Also, the oral manifestations of cp are well documented in literature, there have been few studies that actually investigated the prevelance of oral manifestations in cp patients. Thus the aim of the current proposal is to study the prevelance of oral manifestation of cp. (Du et al. 2010).

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Other
    Time Perspective:
    Cross-Sectional
    Official Title:
    Oral Health Status in a Group of Egyptian Children With Cerebral Palsy: A Cross-sectional Study
    Actual Study Start Date :
    Oct 6, 2022
    Anticipated Primary Completion Date :
    Dec 6, 2022
    Anticipated Study Completion Date :
    May 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Oral manifestations of cerebral palsy patients [baseline]

      assess the oral health status in a group of Egyptian children with cerebral palsy. assess the oral health status in a group of Egyptian children with cerebral palsy. assess the oral health status in a group of Egyptian children with cerebral palsy. assess the oral health status in a group of Egyptian children with cerebral palsy. assess the oral health status in a group of Egyptian children with cerebral palsy. assess the oral health status in a group of Egyptian children with cerebral palsy. assess the oral health status in a group of Egyptian children with cerebral palsy. asses Oral manifestations in cerebral palsy patients

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    4 Years to 14 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    Children diagnosed with Cerebral Palsy

    • Children aged from 4 to 14years old irrespective of sex.

    Exclusion Criteria:
    • The child is uncooperative.

    • Parents that refused to give informed consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The National institute of Neuromotor System in Imbaba, Cairo, Egypt. Cairo Egypt 02

    Sponsors and Collaborators

    • Cairo University

    Investigators

    • Principal Investigator: cairo university, Cairo University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Sara Khairy Mahmoud, doctor, Cairo University
    ClinicalTrials.gov Identifier:
    NCT05650593
    Other Study ID Numbers:
    • oral health in cp patients
    First Posted:
    Dec 14, 2022
    Last Update Posted:
    Dec 14, 2022
    Last Verified:
    Dec 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Sara Khairy Mahmoud, doctor, Cairo University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 14, 2022